To assess if ARID3B modulates changes in adhesion potentially through Wnt signaling, we tested the effects of ARID3B or FZD5 expression (Fig 7A) in ovarian cancer cells on adhesion to ECM components (Fig 7B, 7C, and 7D). Here, FZD5 is linked to ovarian carcinoma.